Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis.
Cerebral vasomotor reactivity in neurodegenerative diseases.
Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse.
The MS Center of Saint Louis: a practice perspective of the impacts of high cost sharing.
Characterizing absolute lymphocyte count profiles in dimethyl fumarate-treated patients with MS: Patient management considerations.
The environmental risk factors in multiple sclerosis susceptibility: A case-control study.
Decline of Neuropsychological Abilities in a Large Sample of Patients with Multiple Sclerosis: A Two-Year Longitudinal Study.
Knowing what's right: Which analgesic is recommended for a patient suffering from demyelinating polyneuropathy and scheduled for rotator-cuff repair?
Motoneuron Death after Human Spinal Cord Injury.
Two Different Types of High-frequency Physical Therapy Promote Improvements in the Balance and Mobility of Persons with Multiple Sclerosis.
Recombinant soluble IFN receptor (sIFNAR2) exhibits intrinsic therapeutic efficacy in a murine model of Multiple Sclerosis.
Refined clinical scoring in comparative EAE studies does not enhance the chance to observe statistically significant differences.
Discovery of a new structural class of competitive hDHODH inhibitors with in vitro and in vivo anti-inflammatory, immunosuppressive effects.
Predictive and reactive grip force responses to rapid load increases in people with multiple sclerosis.
Changes in Multidigit Synergies and Their Feed-Forward Adjustments in Multiple Sclerosis.
Lack of KIR4.1 autoantibodies in Japanese patients with MS and NMO.
Immunogenetics of multiple sclerosis: more questions than answers.
The epidemiology of multiple sclerosis: insights to a causal cascade.
Cognitive screening in Multiple Sclerosis: the Five-Point Test as a substitute for the PASAT in measuring executive function.
The obesity-related pathology and Th17 cells.
Prothrombin and factor X are elevated in multiple sclerosis patients.
Inflammaging and Frailty Status Do Not Result in an Increased Extracellular Vesicle Concentration in Circulation.
Response to letter regarding article 'Comparison of myelin water fraction values in periventricular white matter lesions between multiple sclerosis and neuromyelitis optica spectrum disorder'.
Challenges in the acute management of profound hyponatremia presenting with severe symptoms.
Prospective memory in multiple sclerosis: The impact of cue distinctiveness and executive functioning.
Pages
« first
‹ previous
…
769
770
771
772
773
774
775
776
777
…
next ›
last »